RESEARCH-USE BIOSIMILAR ANTIBODY
Sutimlimab
Monoclonal antibody · IgG4
Sutimlimab is a humanized monoclonal IgG4 antibody. Sutimlimab inhibits complement protein component 1, s subcomponent (C1s). Sutimlimab blocks C3 and C4 activation. Sutimlimab can be used for the research of cold agglutinin disease and complement-mediated hemolytic uremic syndrome.
TARGETC1S
YMonoclonal antibody
CATALOGSC-BS-149
CATALOG NUMBERSC-BS-149
MOLECULAR WEIGHTApprox. 144.8 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Sutimlimab is a humanized monoclonal IgG4 antibody. Sutimlimab inhibits complement protein component 1, s subcomponent (C1s). Sutimlimab blocks C3 and C4 activation. Sutimlimab can be used for the research of cold agglutinin disease and complement-mediated hemolytic uremic syndrome.
Sutimlimab is a recombinant research-use antibody directed against C1S.